103 related articles for article (PubMed ID: 28796699)
1. Serum uric acid levels and hormone therapy type: a retrospective cohort study of postmenopausal women.
Jung JH; Song GG; Lee YH; Kim JH; Hyun MH; Choi SJ
Menopause; 2018 Jan; 25(1):77-81. PubMed ID: 28796699
[TBL] [Abstract][Full Text] [Related]
2. Association of hormone therapy and incident gout: population-based case-control study.
Bruderer SG; Bodmer M; Jick SS; Meier CR
Menopause; 2015 Dec; 22(12):1335-42. PubMed ID: 25968834
[TBL] [Abstract][Full Text] [Related]
3. Reversal of an unfavorable effect of hydrochlorothiazide compared to angiotensin converting enzyme inhibitor on serum uric acid and oxypurine levels by estrogen-progestin therapy in hypertensive postmenopausal women.
Posadzy-Malaczynska A; Rajpold K; Woznicka-Leskiewicz L; Marcinkowska J
Curr Med Res Opin; 2019 Oct; 35(10):1687-1697. PubMed ID: 31033362
[No Abstract] [Full Text] [Related]
4. Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey.
Hak AE; Choi HK
Arthritis Res Ther; 2008; 10(5):R116. PubMed ID: 18822120
[TBL] [Abstract][Full Text] [Related]
5. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
[TBL] [Abstract][Full Text] [Related]
7. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
8. 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment.
Kalleinen N; Polo-Kantola P; Irjala K; Porkka-Heiskanen T; Vahlberg T; Virkki A; Polo O
J Clin Endocrinol Metab; 2008 May; 93(5):1655-61. PubMed ID: 18319308
[TBL] [Abstract][Full Text] [Related]
9. The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
Simon JA; Lin F; Vittinghoff E; Bittner V;
Ann Epidemiol; 2006 Feb; 16(2):138-45. PubMed ID: 16039873
[TBL] [Abstract][Full Text] [Related]
10. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
Im JA; Lee JW; Lee HR; Lee DC
Maturitas; 2006 Apr; 54(1):65-71. PubMed ID: 16198517
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
[TBL] [Abstract][Full Text] [Related]
12. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia.
Sumino H; Ichikawa S; Kanda T; Nakamura T; Sakamaki T
Lancet; 1999 Aug; 354(9179):650. PubMed ID: 10466673
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas.
Reed SD; Cushing-Haugen KL; Daling JR; Scholes D; Schwartz SM
Menopause; 2004; 11(2):214-22. PubMed ID: 15021452
[TBL] [Abstract][Full Text] [Related]
14. Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003-2006.
Zhang D; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
Am J Kidney Dis; 2014 Feb; 63(2):198-205. PubMed ID: 24051078
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of continuous combined hormone therapy and tibolone on body composition in postmenopausal women.
Ziaei S; Moaya M; Faghihzadeh S
Climacteric; 2010 Jun; 13(3):249-53. PubMed ID: 19848555
[TBL] [Abstract][Full Text] [Related]
16. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
17. Relationship between circulating tumor necrosis factor system and bone mass before and after estrogen plus progestogen therapy.
Kim JG; Ku SY; Kim H; Chun SW; Suh CS; Choi YM
Menopause; 2009; 16(3):534-8. PubMed ID: 19225428
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum uric Acid and bone mineral density in the general population and in rats with experimental hyperuricemia.
Zhang D; Bobulescu IA; Maalouf NM; Adams-Huet B; Poindexter J; Park S; Wei F; Chen C; Moe OW; Sakhaee K
J Bone Miner Res; 2015 Jun; 30(6):992-9. PubMed ID: 25491196
[TBL] [Abstract][Full Text] [Related]
19. Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women.
Park JS; Kang S; Ahn CW; Cha BS; Kim KR; Lee HC
Maturitas; 2012 Dec; 73(4):344-8. PubMed ID: 23127592
[TBL] [Abstract][Full Text] [Related]
20. [Basic principles of hormone replacement therapy in the postmenopause].
Dören M
Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
